Stay updated with breaking news from Nasdaq Ocup. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Rating) was the recipient of a significant drop in short interest in March. As of March 31st, there was short interest totalling 675,000 shares, a drop of 25.5% from the March 15th total of 906,400 shares. Based on an average daily volume of 161,500 shares, the days-to-cover ratio is […]
Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Rating) – Analysts at Cantor Fitzgerald lifted their FY2023 earnings per share estimates for shares of Ocuphire Pharma in a note issued to investors on Monday, April 3rd. Cantor Fitzgerald analyst K. Kluska now forecasts that the company will post earnings of $0.17 per share for the year, up […]
Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Rating) – Equities researchers at HC Wainwright issued their Q1 2023 earnings per share estimates for shares of Ocuphire Pharma in a note issued to investors on Friday, March 31st. HC Wainwright analyst M. Caufield expects that the company will post earnings of ($0.24) per share for the quarter. […]
HC Wainwright reissued their buy rating on shares of Ocuphire Pharma (NASDAQ:OCUP – Get Rating) in a research note issued to investors on Friday morning, Benzinga reports. They currently have a $20.00 price target on the stock. HC Wainwright also issued estimates for Ocuphire Pharma’s Q1 2023 earnings at ($0.24) EPS, Q2 2023 earnings at […]
Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Rating) – Analysts at HC Wainwright issued their Q1 2023 earnings per share (EPS) estimates for shares of Ocuphire Pharma in a report issued on Friday, March 31st. HC Wainwright analyst M. Caufield anticipates that the company will earn ($0.24) per share for the quarter. HC Wainwright currently has […]